149 related articles for article (PubMed ID: 31301566)
1. Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites.
Ju Z; Su M; Hong J; La Kim E; Moon HR; Chung HY; Kim S; Jung JH
Eur J Med Chem; 2019 Oct; 180():86-98. PubMed ID: 31301566
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
[TBL] [Abstract][Full Text] [Related]
3. Design of Balanced Cyclooxygenase Inhibitors Based on Natural Anti-inflammatory Ascidian Metabolites and Celecoxib.
Fang J; Shang Z; Kaliaperumal K; Ju Z; Chen FE
ChemMedChem; 2023 Dec; 18(23):e202300468. PubMed ID: 37815017
[TBL] [Abstract][Full Text] [Related]
4. Rationally designed hybrid molecules with appreciable COX-2 inhibitory and anti-nociceptive activities.
Singh P; Shaveta ; Sharma S; Bhatti R
Bioorg Med Chem Lett; 2014 Jan; 24(1):77-82. PubMed ID: 24332492
[TBL] [Abstract][Full Text] [Related]
5. New methyl 5-(halomethyl)-1-aryl-1H-1,2,4-triazole-3-carboxylates as selective COX-2 inhibitors and anti-inflammatory agents: Design, synthesis, biological evaluation, and docking study.
Li SM; Tsai SE; Chiang CY; Chung CY; Chuang TJ; Tseng CC; Jiang WP; Huang GJ; Lin CY; Yang YC; Fuh MT; Wong FF
Bioorg Chem; 2020 Nov; 104():104333. PubMed ID: 33142408
[TBL] [Abstract][Full Text] [Related]
6. Dual COX-2 and 15-LOX inhibition study of novel 4-arylidine-2-mercapto-1-phenyl-1H-imidazolidin-5(4H)-ones: Design, synthesis, docking, and anti-inflammatory activity.
Osman NA; Soltan MK; Rezq S; Flaherty J; Romero DG; Abdelkhalek AS
Arch Pharm (Weinheim); 2024 May; 357(5):e2300615. PubMed ID: 38315093
[TBL] [Abstract][Full Text] [Related]
7. Novel trifluoromethyl ketone derivatives as oral cPLA
Cai N; Gao X; Li W; Yang L; Zhao J; Qu J; Zhou Y
Bioorg Chem; 2024 Jul; 148():107453. PubMed ID: 38761708
[TBL] [Abstract][Full Text] [Related]
8. Biological and anti-inflammatory evaluation of two thiazole compounds in RAW cell line: potential cyclooxygenase-2 specific inhibitors.
Hamade E; Habib A; Hachem A; Hussein AH; Abbas M; Hirz T; Al Masri M; Faour WH
Med Chem; 2012 May; 8(3):401-8. PubMed ID: 22530893
[TBL] [Abstract][Full Text] [Related]
9. Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors.
Mohamed LW; El-Badry OM; El-Ansary AK; Ismael A
Bioorg Chem; 2017 Jun; 72():308-314. PubMed ID: 28500957
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
Lamie PF; Philoppes JN; Rárová L
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and discovery of pyrazolo-pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments.
Dennis Bilavendran J; Manikandan A; Thangarasu P; Sivakumar K
Bioorg Chem; 2020 Jan; 94():103484. PubMed ID: 31796215
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
Grover J; Kumar V; Sobhia ME; Jachak SM
Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W
Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation.
Fan X; Li J; Deng X; Lu Y; Feng Y; Ma S; Wen H; Zhao Q; Tan W; Shi T; Wang Z
Eur J Med Chem; 2020 May; 193():112217. PubMed ID: 32182488
[TBL] [Abstract][Full Text] [Related]
15. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
[TBL] [Abstract][Full Text] [Related]
18. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
19. Novel unsaturated glycyrrhetic acids derivatives: Design, synthesis and anti-inflammatory activity.
Li B; Cai S; Yang YA; Chen SC; Chen R; Shi JB; Liu XH; Tang WJ
Eur J Med Chem; 2017 Oct; 139():337-348. PubMed ID: 28803048
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of Centella asiatica phytosome in a mouse model of phthalic anhydride-induced atopic dermatitis.
Ju Ho P; Jun Sung J; Ki Cheon K; Jin Tae H
Phytomedicine; 2018 Apr; 43():110-119. PubMed ID: 29747743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
